Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:AMED NYSE:CHE NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$105.97+0.2%$95.53$87.95▼$124.43$1.97B0.88238,886 shs216,419 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$485.48+1.0%$439.37$365.20▼$492.30$6.38B0.52203,584 shs165,071 shsOPCHOption Care Health$21.57+1.0%$21.39$18.01▼$36.80$3.35B0.652.69 million shs1.56 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.53%+7.83%+14.80%+13.51%-5.48%AMEDAmedisys0.00%0.00%0.00%0.00%+5.07%CHEChemed-1.95%+4.49%+8.92%+23.55%+1.56%OPCHOption Care Health-2.47%+0.19%+4.14%-23.00%-28.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$105.97+0.2%$95.53$87.95▼$124.43$1.97B0.88238,886 shs216,419 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$485.48+1.0%$439.37$365.20▼$492.30$6.38B0.52203,584 shs165,071 shsOPCHOption Care Health$21.57+1.0%$21.39$18.01▼$36.80$3.35B0.652.69 million shs1.56 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+0.53%+7.83%+14.80%+13.51%-5.48%AMEDAmedisys0.00%0.00%0.00%0.00%+5.07%CHEChemed-1.95%+4.49%+8.92%+23.55%+1.56%OPCHOption Care Health-2.47%+0.19%+4.14%-23.00%-28.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 2.70Moderate Buy$131.0023.62% UpsideAMEDAmedisys 0.00N/AN/AN/ACHEChemed 2.33Hold$501.503.30% UpsideOPCHOption Care Health 2.64Moderate Buy$30.5441.58% UpsideCurrent Analyst Ratings BreakdownLatest AMED, CHE, OPCH, and ADUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2026OPCHOption Care Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy ➝ Neutral$22.006/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$22.005/22/2026ADUSAddus HomeCare Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/18/2026ADUSAddus HomeCare Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Outperform$142.005/15/2026ADUSAddus HomeCare BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderweight$102.00 ➝ $92.005/11/2026OPCHOption Care Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/11/2026OPCHOption Care Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/6/2026OPCHOption Care Health Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$28.005/6/2026ADUSAddus HomeCare Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$150.00 ➝ $142.005/6/2026OPCHOption Care Health Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight(Data available from 7/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.42B1.39$6.51 per share16.28$58.72 per share1.80AMEDAmedisys$2.40B1.38$6.24 per share16.20$38.77 per share2.61CHEChemed$2.53B2.55$24.92 per share19.48$69.15 per share7.02OPCHOption Care Health$5.65B0.60$2.06 per share10.45$8.36 per share2.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$95.91M$5.4119.5915.611.456.89%9.80%7.34%8/3/2026 (Estimated)AMEDAmedisys$43.23M$2.5739.3020.871.343.56%12.91%7.29%N/ACHEChemed$265.24M$18.3526.4618.841.7710.23%27.18%17.38%7/28/2026 (Estimated)OPCHOption Care Health$207.59M$1.2916.7211.721.193.64%18.17%7.16%7/29/2026 (Estimated)Latest AMED, CHE, OPCH, and ADUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/3/2026Q2 2026ADUSAddus HomeCare$1.69N/AN/AN/A$376.27 millionN/A7/29/2026Q2 2026OPCHOption Care Health$0.42N/AN/AN/A$1.42 billionN/A7/28/2026Q2 2026CHEChemed$5.55N/AN/AN/A$665.04 millionN/A5/4/2026Q1 2026ADUSAddus HomeCare$1.52$1.62+$0.10$1.36$366.41 million$363.50 million4/30/2026Q1 2026OPCHOption Care Health$0.37$0.40+$0.03$0.29$1.39 billion$1.35 billion4/23/2026Q1 2026CHEChemed$5.30$5.65+$0.35$4.84$659.22 million$657.51 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.400.49%+10.76%13.08%16 YearsOPCHOption Care HealthN/AN/AN/AN/AN/ALatest AMED, CHE, OPCH, and ADUS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/18/2026CHEChemedquarterly$0.600.55%5/28/20265/28/20266/16/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.081.831.83AMEDAmedisys0.261.361.36CHEChemed0.110.850.83OPCHOption Care Health0.851.641.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AMEDAmedisys94.36%CHEChemed95.85%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.10%AMEDAmedisys2.10%CHEChemed3.33%OPCHOption Care Health1.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare50,65918.67 million17.90 millionOptionableAMEDAmedisys20,00032.89 million32.20 millionOptionableCHEChemed15,81113.27 million12.83 millionOptionableOPCHOption Care Health8,266157.03 million154.36 millionOptionableAMED, CHE, OPCH, and ADUS HeadlinesRecent News About These CompaniesWhy Option Care Health’s (OPCH) Alternate-Site Infusion Model Fits the Site-of-Care ShiftJuly 7 at 7:36 AM | insidermonkey.comOption Care Health: Mildly Interesting After PullbackJuly 5 at 7:37 AM | seekingalpha.comLouisiana State Employees Retirement System Acquires Shares of 46,000 Option Care Health, Inc. $OPCHJuly 4 at 4:31 AM | marketbeat.com192,894 Shares in Option Care Health, Inc. $OPCH Purchased by Fideuram Intesa Sanpaolo Private Banking S.P.A.July 4 at 3:45 AM | marketbeat.comCorient Private Wealth LLC Has $953,000 Stock Position in Option Care Health, Inc. $OPCHJuly 3, 2026 | marketbeat.com1 stock under $50 to consider right now and 2 we find riskyJune 30, 2026 | msn.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Rating of "Moderate Buy" by AnalystsJune 27, 2026 | americanbankingnews.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by AnalystsJune 27, 2026 | marketbeat.comOption Care Health, Inc. $OPCH Stock Holdings Trimmed by Riverbridge Partners LLCJune 24, 2026 | marketbeat.comIs Option Care Health, Inc. (OPCH) A Good Stock To Buy Now?June 22, 2026 | finance.yahoo.comArrowstreet Capital Limited Partnership Acquires 247,118 Shares of Option Care Health, Inc. $OPCHJune 16, 2026 | marketbeat.comArvin Capital Management LP Reduces Stock Position in Option Care Health, Inc. $OPCHJune 14, 2026 | marketbeat.comOption Care Health (OPCH) stock trades up, here is whyJune 9, 2026 | msn.comOption Care Health (NASDAQ:OPCH) Upgraded at The Goldman Sachs GroupJune 9, 2026 | marketbeat.comBillionaire Stanley Druckenmiller’s Long-Term Healthcare Stock Pick: Option Care Health (OPCH)June 8, 2026 | finance.yahoo.comNorges Bank Makes New Investment in Option Care Health, Inc. $OPCHJune 8, 2026 | marketbeat.comOption Care Health Appoints Robert Okunski as Vice President, Investor RelationsJune 4, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Option Care Health (OPCH)June 4, 2026 | theglobeandmail.comHow The Option Care Health (OPCH) Investment Story Is Evolving Without New Analyst CommentaryJune 1, 2026 | finance.yahoo.com2 Reasons to Sell OPCH and 1 Stock to Buy InsteadJune 1, 2026 | finance.yahoo.comOption Care Health Awarded TIME's World's Most Impactful Companies 2026 RankingJune 1, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesGravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026Draining the Tank: Big Oil Runs on FumesBy Jeffrey Neal Johnson | June 17, 20263 Tech ETFs That Could Bounce Back After the AI SelloffBy Nathan Reiff | June 20, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 20263 Stocks to Watch If the Strait of Hormuz ReopensBy Chris Markoch | June 17, 2026AMED, CHE, OPCH, and ADUS Company DescriptionsAddus HomeCare NASDAQ:ADUS$105.97 +0.24 (+0.23%) Closing price 04:00 PM EasternExtended Trading$106.00 +0.03 (+0.03%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Amedisys NASDAQ:AMEDAmedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$485.48 +4.98 (+1.04%) Closing price 03:59 PM EasternExtended Trading$485.38 -0.10 (-0.02%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Option Care Health NASDAQ:OPCH$21.57 +0.21 (+0.98%) Closing price 04:00 PM EasternExtended Trading$21.56 -0.02 (-0.07%) As of 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Apple and Broadcom Forge a Decade-Long Silicon Fortress SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity Palantir's CEO Just Called Out OpenAI and Anthropic Silicon Starvation: Amazon Feasts on Legacy GPUs GE Vernova’s Power Surge Turns the Grid Into an AI Trade 3 Quiet AI Revenue Accelerators With Sales Growth Outpacing Peers Abivax: Wall Street Catches Up to the Data Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
